On October 26, we presented the webinar: Operational Expertise in Action: Unleashing the Potential of Decentralized Clinical Trials
During this webinar, our speaker and co-hosts, dived into Decentralized Clinical Trials and discuss the case study: COVID-RED; a 17,000 person study testing AI’s ability to detect and alert users to COVID-19 infection in real-time.
Points that are discussed:
- Logistical considerations for launching a Decentralized Clinical Trial
- Decentralized Clinical Trials enables Flexibility/Adaptability in Evolving Pandemic Conditions
- Participant engagement & compliance strategies
- Data analysis & privacy concerns
- Study Results/success of Decentralized Clinical Trial case study
Speaker: Brianna Mae Goodale, PhD
Co-Hosts: Jon Bouwman, MBA & David Ong MD, PhD, PharmD, & MSc
Watch the replay below:
For more information about COVID-RED, please visit: COVID-Red
On September 6, our partner ReSViNET presented the webinar: “RSV and Asthma” Prof Tina Hartert, MD, MPH shared her insights on RSV in relationship to asthma. Her study of almost two thousand children has identified that delay in early life ...
On May 10, our partner ReSViNET presented the webinar: Progress in RSV Vaccines and Monoclonal Antibodies In this webinar, Professor Barney Graham, MD, PhD, shared his views on the lanscape of RSV therapeutics. The webinar was hosted by Prof. D...
On April 26, we presented the webinar: RSV vaccine development for all ages, what lies ahead of us? In this webinar, Prof. Louis Bont, shared his views on the burden of RSV infections across generations and the latest advancements in monocl...